1. Home
  2. GNL vs AAPG Comparison

GNL vs AAPG Comparison

Compare GNL & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Net Lease Inc.

GNL

Global Net Lease Inc.

HOLD

Current Price

$8.88

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$18.29

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GNL
AAPG
Founded
2011
2009
Country
United States
China
Employees
56
767
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GNL
AAPG
Price
$8.88
$18.29
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$9.67
$48.40
AVG Volume (30 Days)
2.6M
14.3K
Earning Date
05-05-2026
05-20-2026
Dividend Yield
7.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$290.34
Revenue Next Year
$1.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.77
$16.36
52 Week High
$10.04
$48.45

Technical Indicators

Market Signals
Indicator
GNL
AAPG
Relative Strength Index (RSI) 42.73 45.77
Support Level $8.12 $16.64
Resistance Level $9.66 $20.40
Average True Range (ATR) 0.22 0.54
MACD 0.00 -0.01
Stochastic Oscillator 12.50 19.27

Price Performance

Historical Comparison
GNL
AAPG

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: